Literature DB >> 20215413

CYP2C9-CYP3A4 protein-protein interactions: role of the hydrophobic N terminus.

Murali Subramanian1, Harrison Tam, Helen Zheng, Timothy S Tracy.   

Abstract

Cytochromes P450 (P450s) interact with redox transfer proteins, including P450 reductase (CPR) and cytochrome b(5) (b5), all being membrane-bound. In multiple in vitro systems, P450-P450 interactions also have been observed, resulting in alterations in enzymatic activity. The current work investigated the effects and mechanisms of interaction between CYP2C9 and CYP3A4 in a reconstituted system. CYP2C9-mediated metabolism of S-naproxen and S-flurbiprofen was inhibited up to 80% by coincubation with CYP3A4, although K(m) values were unchanged. Increasing CYP3A4 concentrations increased the degree of inhibition, whereas increasing CPR concentrations resulted in less inhibition. Addition of b5 only marginally affected the magnitude of inhibition. In contrast, CYP2C9 did not alter the CYP3A4-mediated metabolism of testosterone. The potential role of the hydrophobic N terminus on these interactions was assessed by incubating truncated CYP2C9 with full-length CYP3A4, and vice versa. In both cases, the inhibition was fully abolished, indicating an important role for hydrophobic forces in CYP2C9-CYP3A4 interactions. Finally, a CYP2C9/CYP3A4 heteromer complex was isolated by coimmunoprecipitation techniques, confirming the physical interaction of the proteins. These results show that the N-terminal membrane binding domains of CYP2C9 and CYP3A4 are involved in heteromer complex formation and that at least one consequence is a reduction in CYP2C9 activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215413      PMCID: PMC2879957          DOI: 10.1124/dmd.109.030155

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  46 in total

1.  Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase.

Authors:  W L Backes; C J Batie; G F Cawley
Journal:  Biochemistry       Date:  1998-09-15       Impact factor: 3.162

2.  Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase.

Authors:  A Bridges; L Gruenke; Y T Chang; I A Vakser; G Loew; L Waskell
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

3.  Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions.

Authors:  H Yamazaki; E M Gillam; M S Dong; W W Johnson; F P Guengerich; T Shimada
Journal:  Arch Biochem Biophys       Date:  1997-06-15       Impact factor: 4.013

4.  Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.

Authors:  Y Tan; C J Patten; T Smith; C S Yang
Journal:  Arch Biochem Biophys       Date:  1997-06-01       Impact factor: 4.013

5.  Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism.

Authors:  D N Li; M P Pritchard; S P Hanlon; B Burchell; C R Wolf; T Friedberg
Journal:  J Pharmacol Exp Ther       Date:  1999-05       Impact factor: 4.030

Review 6.  Zonation of metabolism and gene expression in liver.

Authors:  K Jungermann
Journal:  Histochem Cell Biol       Date:  1995-02       Impact factor: 4.304

Review 7.  Zonation of hepatic cytochrome P-450 expression and regulation.

Authors:  T Oinonen; K O Lindros
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

8.  Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregation.

Authors:  A C Kempf; U M Zanger; U A Meyer
Journal:  Arch Biochem Biophys       Date:  1995-08-20       Impact factor: 4.013

9.  Involvement of multiple cytochrome P450 isoforms in naproxen O-demethylation.

Authors:  T S Tracy; C Marra; S A Wrighton; F J Gonzalez; K R Korzekwa
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

10.  The alpha-helical membrane spanning domain of cytochrome b5 interacts with cytochrome P450 via nonspecific interactions.

Authors:  Scott B Mulrooney; David R Meinhardt; Lucy Waskell
Journal:  Biochim Biophys Acta       Date:  2004-11-01
View more
  26 in total

1.  Effect of homomeric P450-P450 complexes on P450 function.

Authors:  James R Reed; J Patrick Connick; Dongmei Cheng; George F Cawley; Wayne L Backes
Journal:  Biochem J       Date:  2012-09-15       Impact factor: 3.857

2.  Interactions among cytochromes P450 in microsomal membranes: oligomerization of cytochromes P450 3A4, 3A5, and 2E1 and its functional consequences.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; Elena V Sineva; James R Halpert
Journal:  J Biol Chem       Date:  2014-12-22       Impact factor: 5.157

3.  Identification of cytochrome P450 2C2 protein complexes in mouse liver.

Authors:  Bin Li; Peter Yau; Byron Kemper
Journal:  Proteomics       Date:  2011-08       Impact factor: 3.984

Review 4.  Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges.

Authors:  Eric F Johnson; J Patrick Connick; James R Reed; Wayne L Backes; Manoj C Desai; Lianhong Xu; D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2013-10-15       Impact factor: 3.922

5.  Altered CYP2C9 activity following modulation of CYP3A4 levels in human hepatocytes: an example of protein-protein interactions.

Authors:  Diane Ramsden; Donald J Tweedie; Tom S Chan; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2014-08-25       Impact factor: 3.922

6.  Development of an in vitro system with human liver microsomes for phenotyping of CYP2C9 genetic polymorphisms with a mechanism-based inactivator.

Authors:  Darcy R Flora; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2011-12-28       Impact factor: 3.922

7.  Toward a systems approach to the human cytochrome P450 ensemble: interactions between CYP2D6 and CYP2E1 and their functional consequences.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; John T Rodgers; Thomas H Rushmore; Jeffrey P Jones
Journal:  Biochem J       Date:  2017-10-10       Impact factor: 3.857

8.  Interactions between cytochromes P450 2B4 (CYP2B4) and 1A2 (CYP1A2) lead to alterations in toluene disposition and P450 uncoupling.

Authors:  James R Reed; George F Cawley; Wayne L Backes
Journal:  Biochemistry       Date:  2013-05-28       Impact factor: 3.162

9.  Interactions between CYP2E1 and CYP2B4: effects on affinity for NADPH-cytochrome P450 reductase and substrate metabolism.

Authors:  Cesar Kenaan; Erin V Shea; Hsia-lien Lin; Haoming Zhang; Matthew J Pratt-Hyatt; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2012-10-05       Impact factor: 3.922

Review 10.  The functional effects of physical interactions involving cytochromes P450: putative mechanisms of action and the extent of these effects in biological membranes.

Authors:  James R Reed; Wayne L Backes
Journal:  Drug Metab Rev       Date:  2016-08       Impact factor: 4.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.